Wechat

Website

Chinese Journal of Oncology Prevention and Treatment ›› 2020, Vol. 12 ›› Issue (2): 169-174.doi: 10.3969/j.issn.1674-5671.2020.02.11

Previous Articles     Next Articles

Analysis of the composition of immune cells in the bladder tumor microenvironment based on single-cell mass cytometry

  

  1. Center for Genomic and Personalized Medicine,Guangxi Medical University;Department of Urology,the First Affiliated Hospital of Guangxi Medical University;Department of Urology,Guangxi Medical University Cancer Hospital
  • Online:2020-04-25 Published:2020-05-05

Abstract: Objective  To investigate the effect of single-cell mass cytometry(CyTOF) analysis on the characteristics of infiltrating immune cell subsets in bladder cancer tissues and paracancerous tissues,providing a new strategy for the study of bladder cancer heterogeneity. Methods The cancer tissues and paracancerous tissues of 4 bladder cancer patients were collected and prepared into single-cell suspensions by enzymatic hydrolysis and mechanical dissociation. CyTOF was used to detect the expression of 26 immune-related markers in tumor-infiltrating immune cells. Results The bladder CD45+ immune cells were divided into 25 subgroups (7 CD4+ T cell clusters,8 CD8+T cell clusters,4 macrophage clusters,2 B cell clusters,1 dendritic cell cluster,and 3 other types immune cell clusters) by cell similarity analysis. The contents of infiltrating immune cell subpopulations in bladder cancer tissues and paracancerous tissues were different. T cells were more abundant in bladder cancer tissues at 76.73%,whereas B cells and macrophages were more abundant in paracancerous tissues,accounting for 15.20% and 23.82%,respectively. The average proportion of CD4+ Treg cells in bladder cancer tissues was higher than that in paracancerous tissues(2.20% vs 0.81%,P=0.016). Conclusions CyTOF can effectively distinguish the immune cell subsets in the bladder tumor microenvironment and detect tumor heterogeneity,providing a basis for the accurate treatment of bladder cancer.

Key words: Bladder cancer, Single-cell mass cytometry, Tumor microenvironment, Immune characteristics

CLC Number: 

  • R737.14